Sumatriptan nasal spray in the acute treatment of migraine in adolescents and children.

Callenbach, Petra M C; Pels, Lise P M; Mulder, Paul G H; Linssen, Wim H J P; Gooskens, Rob H J M; van der Zwan, Jan L; Brouwer, Oebele F

Callenbach, Petra M C; Pels, Lise P M; Mulder, Paul G H; Linssen, Wim H J P; Gooskens, Rob H J M; van der Zwan, Jan L; Brouwer, Oebele F.

Afiliação

Callenbach PM; Department of Neurology, University Medical Centre Groningen, University of Groningen, P.O. Box 30 001 9700 RB Groningen, The Netherlands. p.m.c.tijink@neuro.umcg.nl

Eur J Paediatr Neurol ; 11(6): 325-30, 2007 Nov.

Article em En | MEDLINE | ID: mdl-17428708

RESUMO

About 4-10% of children and adolescents suffer from migraine. In the last few years, several studies have been performed to assess the efficacy and safety of triptans for the acute treatment of migraine in children and adolescents. Only sumatriptan nasal spray has been approved for the treatment of acute migraine with or without aura in adolescents aged 12-17 years in Europe. This review describes the results of the studies with sumatriptan nasal spray that have been performed in children and adolescents, including a study performed in the Netherlands.

Assuntos

Transtornos de Enxaqueca/tratamento farmacológico; Agonistas do Receptor de Serotonina/administração & dosagem; Sumatriptana/administração & dosagem; Administração Intranasal; Adolescente; Criança; Pré-Escolar; Ensaios Clínicos como Assunto; Humanos

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Agonistas do Receptor de Serotonina / Sumatriptana / Transtornos de Enxaqueca Limite: Adolescent / Child / Child, preschool / Humans Idioma: En Ano de publicação: 2007 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links